Shigella sonnei: virulence and antibiotic resistance
- PMID: 32929595
- PMCID: PMC7489455
- DOI: 10.1007/s00203-020-02034-3
Shigella sonnei: virulence and antibiotic resistance
Abstract
Shigella sonnei is the emerging pathogen globally, as it is the second common infectious species of shigellosis (bloody diarrhoea) in low- and middle-income countries (LMICs) and the leading one in developed world. The multifactorial processes and novel mechanisms have been identified in S. sonnei, that are collectively playing apart a substantial role in increasing its prevalence, while replacing the S. flexneri and other Gram-negative gut pathogens niche occupancy. Recently, studies suggest that due to improvement in sanitation S. sonnei has reduced cross-immunization from Plesiomonas shigelliodes (having same O-antigen as S. sonnei) and also found to outcompete the two major species of Enterobacteriaceae family (Shigella flexneri and Escherichia coli), due to encoding of type VI secretion system (T6SS). This review aimed to highlight S. sonnei as an emerging pathogen in the light of recent research with pondering aspects on its epidemiology, transmission, and pathogenic mechanisms. Additionally, this paper aimed to review S. sonnei disease pattern and related complications, symptoms, and laboratory diagnostic techniques. Furthermore, the available treatment reigns and antibiotic-resistance patterns of S. sonnei are also discussed, as the ciprofloxacin and fluoroquinolone-resistant S. sonnei has already intensified the global spread and burden of antimicrobial resistance. In last, prevention and controlling strategies are briefed to limit and tackle S. sonnei and possible future areas are also explored that needed more research to unravel the hidden mysteries surrounding S. sonnei.
Keywords: Antimicrobial resistance; Escherichia coli; LMICs; Shigella flexneri; Shigella sonnei; Virulence.
Conflict of interest statement
None to declare.
Figures

Similar articles
-
Shigella sonnei Encodes a Functional T6SS Used for Interbacterial Competition and Niche Occupancy.Cell Host Microbe. 2017 Jun 14;21(6):769-776.e3. doi: 10.1016/j.chom.2017.05.004. Cell Host Microbe. 2017. PMID: 28618272
-
Phylogenetic and Evolutionary Analysis Reveals the Recent Dominance of Ciprofloxacin-Resistant Shigella sonnei and Local Persistence of S. flexneri Clones in India.mSphere. 2020 Oct 7;5(5):e00569-20. doi: 10.1128/mSphere.00569-20. mSphere. 2020. PMID: 33028681 Free PMC article.
-
Clinical implications of reduced susceptibility to fluoroquinolones in paediatric Shigella sonnei and Shigella flexneri infections.J Antimicrob Chemother. 2016 Mar;71(3):807-15. doi: 10.1093/jac/dkv400. Epub 2015 Dec 17. J Antimicrob Chemother. 2016. PMID: 26679253 Free PMC article.
-
Shigellosis in Taiwan: An old enteric pathogen with changing epidemiology and increasing antimicrobial resistance.J Microbiol Immunol Infect. 2024 Jun;57(3):346-353. doi: 10.1016/j.jmii.2023.10.015. Epub 2023 Nov 3. J Microbiol Immunol Infect. 2024. PMID: 37951802 Review.
-
Pathogenicity and virulence of Shigella sonnei: A highly drug-resistant pathogen of increasing prevalence.Virulence. 2023 Dec;14(1):2280838. doi: 10.1080/21505594.2023.2280838. Epub 2023 Nov 23. Virulence. 2023. PMID: 37994877 Free PMC article. Review.
Cited by
-
Safety and Immunogenicity of a Shigella Bivalent Conjugate Vaccine (ZF0901) in 3-Month- to 5-Year-Old Children in China.Vaccines (Basel). 2021 Dec 28;10(1):33. doi: 10.3390/vaccines10010033. Vaccines (Basel). 2021. PMID: 35062694 Free PMC article.
-
Characterization of Antibiotic Treatment among Children Aged 0-59 Months Hospitalized for Acute Bacterial Gastroenteritis in Israel.Antibiotics (Basel). 2024 Jan 8;13(1):64. doi: 10.3390/antibiotics13010064. Antibiotics (Basel). 2024. PMID: 38247623 Free PMC article.
-
Dissecting in Vitro the Activation of Human Immune Response Induced by Shigella sonnei GMMA.Front Cell Infect Microbiol. 2022 Feb 3;12:767153. doi: 10.3389/fcimb.2022.767153. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35186786 Free PMC article.
-
Towards geospatially-resolved public-health surveillance via wastewater sequencing.Nat Commun. 2024 Sep 27;15(1):8386. doi: 10.1038/s41467-024-52427-x. Nat Commun. 2024. PMID: 39333485 Free PMC article.
-
Anti-virulence and bactericidal activities of Stattic against Shigella sonnei.Appl Environ Microbiol. 2023 Dec 21;89(12):e0107423. doi: 10.1128/aem.01074-23. Epub 2023 Nov 30. Appl Environ Microbiol. 2023. PMID: 38032177 Free PMC article.
References
-
- Al-Dahmoshi HOM, Al-Khafaji NSK, Al-Allak MH, Salman WK, Alabbasi AH. A review on shigellosis: pathogenesis and antibiotic resistance. Drug Invent Today. 2020;14:793–798.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical